Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya
about
Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged childrenLong-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.Toward a surrogate marker of malaria exposure: modeling longitudinal antibody measurements under outbreak conditionsRandomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malariaSpatial variation in genetic diversity and natural selection on the thrombospondin-related adhesive protein locus of Plasmodium vivax (PvTRAP).Research priorities for the development and implementation of serological tools for malaria surveillance.Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigensAntibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemicSero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionHumoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adultsPre-erythrocytic malaria vaccines: towards greater efficacy.Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in MyanmarLow prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocystsAntibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.Immune Responses in Malaria.Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.
P2860
Q24792246-9B6E26ED-6C68-468C-8FC8-451DD2112F9BQ33305467-39510764-6C49-494A-8CCE-C745867FA9DEQ33512110-D5FF2F74-BFAC-455D-9BD2-91A4E4E6D119Q33577093-65D4FA87-DEAF-4CC9-83A8-E0F74B1106F2Q33982957-8BE86641-AA9B-44CF-ABB2-62C100E04ACBQ34170122-640D0774-3BDD-4718-B0C8-430B9245F275Q34301187-1B47C4B2-742E-4662-B64B-AD4CB0DB2BBDQ34379539-79C3843F-2969-4E3E-85C7-22143010516DQ34500035-5E14B39D-DAA0-46D8-91D1-2252B71AB7DFQ34778078-21A10FD1-F0A6-45C8-835B-93C2DAC053EAQ35003931-FEBE78CF-0A4C-46A1-8C27-49C96A925212Q35016677-5AE8B6EA-1811-418C-BEF4-21AA4C6A0366Q35998522-0605E93A-64EA-4522-88D8-A6234941595DQ36004060-2ABDE535-3FEE-4D6B-8A80-35ED8D5BB701Q36123104-9E2024BE-7EB1-4B99-B7CC-A578BE5E51C7Q36403400-C38BA8D3-4B71-4CD0-9A3C-332B494FD5B5Q36539553-D9680C7D-01D6-47AA-95B6-064A02132B88Q36702998-7542C8DA-A2BC-4C78-A04C-E7FA061690F5Q36908779-14391880-BDB4-48D6-AF77-0325F142125CQ36974401-196C40C1-EBC8-4D26-913F-EED0BED36B99Q37015435-10A4001B-6042-481A-924C-9089146C3063Q37023939-CA85BB2F-38EF-4507-AE85-BD39E8C98A66Q40015116-CEADE6B1-C174-4B99-BFF9-F188B3A20761Q40259888-224D43F3-88A3-4456-B60F-9BD58D506024Q46758381-59419239-DBC0-42FC-B561-A7771CE52DE7Q51648048-A29E9AF5-53B8-463D-BC8F-AEFA8CA1D58EQ52715900-8A073B00-2FDC-43F6-9A3D-8ED417FF40A0
P2860
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@ast
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@en
type
label
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@ast
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@en
prefLabel
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@ast
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@en
P2860
P50
P921
P1476
Antibodies to the Plasmodium f ...... on in a highland area of Kenya
@en
P2093
Christopher L King
P Odada Sumba
P2860
P304
P356
10.1128/IAI.71.8.4320-4325.2003
P407
P577
2003-08-01T00:00:00Z